Fennec Pharmaceuticals Inc. (FENC)
NASDAQ: FENC · IEX Real-Time Price · USD
9.57
-0.13 (-1.34%)
At close: Apr 18, 2024, 4:00 PM
9.86
+0.29 (3.03%)
After-hours: Apr 18, 2024, 7:06 PM EDT
Fennec Pharmaceuticals Market Cap
Fennec Pharmaceuticals has a market cap or net worth of $259.35 million as of April 18, 2024. Its market cap has increased by 9.94% in one year.
Market Cap
259.35M
Enterprise Value
275.81M
1-Year Change
9.94%
Ranking
Category
Stock Price
$9.57
Market Cap Chart
Since December 31, 2004, Fennec Pharmaceuticals's market cap has increased from $65.80M to $259.35M, an increase of 294.14%. That is a compound annual growth rate of 7.36%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 17, 2024 | 258.40M | -5.45% |
Apr 16, 2024 | 273.30M | -0.65% |
Apr 15, 2024 | 275.10M | -1.54% |
Apr 12, 2024 | 279.40M | -3.15% |
Apr 11, 2024 | 288.50M | 1.51% |
Apr 10, 2024 | 284.20M | -2.03% |
Apr 9, 2024 | 290.10M | 0.55% |
Apr 8, 2024 | 288.50M | 1.33% |
Apr 5, 2024 | 284.70M | -2.03% |
Apr 4, 2024 | 290.60M | 1.29% |
Apr 3, 2024 | 286.90M | -1.98% |
Apr 2, 2024 | 292.70M | 1.39% |
Apr 1, 2024 | 288.70M | -2.53% |
Mar 28, 2024 | 296.20M | 0.34% |
Mar 27, 2024 | 295.20M | 1.76% |
Mar 26, 2024 | 290.10M | -0.99% |
Mar 25, 2024 | 293.00M | 1.84% |
Mar 22, 2024 | 287.70M | -2.41% |
Mar 21, 2024 | 294.80M | - |
Mar 20, 2024 | 294.80M | 0.55% |
Mar 19, 2024 | 293.20M | -0.54% |
Mar 18, 2024 | 294.80M | 11.37% |
Mar 15, 2024 | 264.70M | -0.60% |
Mar 14, 2024 | 266.30M | 0.99% |
Mar 13, 2024 | 263.70M | 1.85% |
View and export this data all the way back to 2004.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Pulmonx | 287.87M |
XBiotech | 286.41M |
TriSalus Life Sciences | 285.93M |
XOMA Corporation | 282.97M |
Verastem | 280.02M |
Sanara MedTech | 278.09M |
Ventyx Biosciences | 276.71M |
EDAP TMS | 275.68M |